NLP enables humans and computers to communicate in ways never imagined a few short years ago. The results have practical implications for anyone working in healthcare.
By John Halamka, M.D., M.S., Diercks President, Mayo Clinic…
Continue Reading
Leaders from The Baton Rouge Clinic (TBRC) visited Mayo Clinic’s campus in Jacksonville, Florida, looking for insight and fresh ideas to support their growing organization.
According to Shunn Phillips, CPA, CHC, chief financial officer, the…
Continue Reading
Guidelines and guardrails for the safe use of AI require more than regulation. The Coalition for Health AI has created a framework to reduce these risks and improve the safety and effectiveness of these…
Continue Reading
Micky Tripathi, the former assistant secretary for technology policy at the U.S. Department of Health and Human Services and National Coordinator for Health IT, has reportedly accepted a new post overseeing artificial intelligence at Mayo Clinic. We…
Continue Reading
Tucson Medical Center (TMC), the flagship 600-bed hospital of TMC Health in Arizona, faced a critical inflection point. Emerging from the challenges of the COVID-19 pandemic, the hospital needed more than just recovery—it needed…
Continue Reading
Something all hospitals have in common is policies. Lots of them. Just ask Susan Knotts, R.N., B.S.N., clinical nurse manager, Women and Newborn Unit, Memorial Health System (MHS) in Marietta, Ohio. At least every…
Continue Reading
Image by wavebreakmedia_micro on Freepik
What You Should Know:
– A recent study published in Mayo Clinic Proceedings indicates that occupational burnout rates among physicians in the United States are decreasing after reaching a peak in…
Continue Reading
The capabilities of generative AI continue to grow. Using them wisely will likely improve clinical decision making.
By Paul Cerrato, MA, senior research analyst and communications specialist and John Halamka, M.D., Diercks President, Mayo Clinic…
Continue Reading
Source: MyPhenome genetic obesity test
What You Should Know:
– Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
– The research will evaluate…
Continue Reading
The Oxford Dictionary says disease is a disorder of structure or function, especially one that has a known cause and a distinctive group of symptoms, signs, or anatomical changes. It’s time to rethink that…
Continue Reading
